Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pivotal trial of NovaCaps given green light by EMEA

Sep. 16, 2004

SPA for phase III study of glufosfamide for metastatic pancreatic cancer

Sep. 15, 2004

Iressa studied in new head-to-head trial for NSCLC

Sep. 15, 2004

Oncomer converts solitary tumor into bloodless mass

Sep. 15, 2004

AustCancer acquires North American rights to RP-101

Sep. 15, 2004

New phase IIIb study of Tarceva in advanced NSCLC

Sep. 15, 2004

Novel HDAC inhibitors prepared and tested at Oxford GlycoSciences

Sep. 15, 2004

Bonefos accepted for priority review

Sep. 14, 2004

Assessment of survival of advanced NSCLC patients treated with gefitinib

Sep. 13, 2004

Insmed's rhIGFBP-3 enters phase I study

Sep. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...